Immunobiology of visceral leishmaniasis
Open Access
- 1 January 2012
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 3, 21798
Abstract
Visceral leishmaniasis (VL), commonly known as kala-azar, is caused by Leishmania donovani and Leishmania infantum (Leishmania chagasi in the Americas). These Leishmania species infect macrophages throughout the viscera, and parasites are typically found in the spleen, liver, and bone marrow. Patients with active disease typically exhibit marked immunosuppression, lack reactivity to the Leishmania skin test (LST), a delayed type hypersensitivity test, and their peripheral blood mononuclear cells (PBMC) fail to respond when stimulated with leishmanial antigens in vitro. However, most people infected with visceralizing species of Leishmania never develop disease. Understanding immune failure and the underlying immune mechanism that lead to disease as well as control of infection are key questions for research in this field. In this review, we discuss immunological events described in human and experimental VL and how these can affect the outcome of infection.Keywords
This publication has 97 references indexed in Scilit:
- Murine visceral leishmaniasis: IgM and polyclonal B‐cell activation lead to disease exacerbationEuropean Journal of Immunology, 2010
- IL-27 Is a Key Regulator of IL-10 and IL-17 Production by Human CD4+ T CellsThe Journal of Immunology, 2009
- IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovaniJournal of Clinical Investigation, 2009
- B7-H1 Blockade Increases Survival of Dysfunctional CD8+ T Cells and Confers Protection against Leishmania donovani InfectionsPLOS Pathogens, 2009
- Th17 cells in human diseaseImmunological Reviews, 2008
- Mechanism of T cell tolerance induction by murine hepatic Kupffer cellsHepatology, 2008
- Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasisJournal of Experimental Medicine, 2007
- The Schistosoma mansoni Hepatic Egg Granuloma Provides a Favorable Microenvironment for Sustained Growth of Leishmania donovaniThe American Journal of Pathology, 2006
- Interactions of malnutrition and immune impairment, with specific reference to immunity against parasitesParasite Immunology, 2006
- Distinct roles for IL‐6 and IL‐12p40 in mediating protection against Leishmania donovani and the expansion of IL‐10+ CD4+ T cellsEuropean Journal of Immunology, 2006